Compare YELP & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YELP | OPK |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2011 | 2011 |
| Metric | YELP | OPK |
|---|---|---|
| Price | $25.66 | $1.22 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $29.17 | $1.60 |
| AVG Volume (30 Days) | 1.3M | ★ 3.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.15 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $1,464,955,000.00 | $606,879,000.00 |
| Revenue This Year | $2.19 | N/A |
| Revenue Next Year | $2.34 | $4.24 |
| P/E Ratio | $87.77 | ★ N/A |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $19.60 | $0.98 |
| 52 Week High | $35.26 | $1.61 |
| Indicator | YELP | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 31.12 |
| Support Level | $23.85 | $1.11 |
| Resistance Level | $27.23 | $1.25 |
| Average True Range (ATR) | 1.02 | 0.06 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 41.31 | 10.13 |
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.